Recurrent Malignant Solid Neoplasm Not Yet Recruiting Phase 1 / 2 Trials for Pepinemab (DB15155)

IndicationStatusPhase
DBCOND0082715 (Recurrent Malignant Solid Neoplasm)Not Yet Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03205644VX15/2503 in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid TumorsTreatment